Published in AIDS on January 23, 2004
Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count < 200 cells/microl when viral replication is suppressed. AIDS (2007) 1.85
Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Ann Intern Med (2007) 1.75
CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults. AIDS (2005) 1.68
Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med (2011) 1.42
Sex, politics, and religion: why AIDS is a secular issue. J Int Assoc Physicians AIDS Care (Chic) (2004) 1.40
Twenty-five years of AIDS. CMAJ (2006) 1.39
The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum. Clin Pharmacol Ther (2004) 1.33
Effect of alcohol use and highly active antiretroviral therapy on plasma levels of hepatitis C virus (HCV) in patients coinfected with HIV and HCV. Clin Infect Dis (2005) 1.32
Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection. Clin Infect Dis (2002) 1.30
Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response. Vaccine (2004) 1.23
Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. Clin Pharmacokinet (2010) 1.21
Quality of life of patients with advanced HIV/AIDS: measuring the impact of both AIDS-defining events and non-AIDS serious adverse events. J Acquir Immune Defic Syndr (2009) 1.19
Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa. BMC Infect Dis (2006) 1.07
Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10. AIDS (2002) 1.05
Time-dependent interaction between lopinavir/ritonavir and fexofenadine. J Clin Pharmacol (2006) 1.02
Inaccuracy of death certificate diagnosis of tuberculosis and potential underdiagnosis of TB in a region of high HIV prevalence. Clin Dev Immunol (2012) 0.99
Development and validation of the HIV Medication Readiness Scale. Assessment (2007) 0.97
Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use. AIDS (2006) 0.97
The role of psychological and behavioral variables in quality of life and the experience of bodily pain among persons living with HIV. J Pain Symptom Manage (2008) 0.97
Systematic review of the effectiveness of training programs in writing for scholarly publication, journal editing, and manuscript peer review (protocol). Syst Rev (2013) 0.95
Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review. Transfusion (2005) 0.88
Inhibition of human cytochrome p450 metabolism by blended herbal products and vitamins. J Pharm Pharm Sci (2011) 0.87
Connection domain mutations in treatment-experienced patients in the OPTIMA trial. J Acquir Immune Defic Syndr (2010) 0.85
Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial. PLoS One (2011) 0.82
The Feasibility, Accuracy, and Impact of Xpert MTB/RIF Testing in a Remote Aboriginal Community in Canada. Chest (2015) 0.81
Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV disease. J Acquir Immune Defic Syndr (2013) 0.80
Health of prisoners, and the public health: no man is an island. J Int Assoc Physicians AIDS Care (Chic) (2004) 0.80
Attenuated Salmonella typhimurium SL3261 as a vaccine vector for recombinant antigen in rabbits. J Immunol Methods (2005) 0.79
In vitro and in vivo activity of combination antimicrobial agents on Haemophilus ducreyi. J Antimicrob Chemother (2005) 0.79
High HIV knowledge relates to low stigma in pharmacists and university health science students in Guyana, South America. Int J Infect Dis (2010) 0.79
Oral antibiotic therapy for the treatment of infective endocarditis: a systematic review. BMC Infect Dis (2014) 0.79
Effect of treatment interruption and intensification of antiretroviral therapy on health-related quality of life in patients with advanced HIV: a randomized, controlled trial. Med Decis Making (2011) 0.79
HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal. PLoS One (2011) 0.78
Design and methods of the MAINTAIN study: a randomized controlled clinical trial of micronutrient and antioxidant supplementation in untreated HIV infection. Contemp Clin Trials (2010) 0.78
Interaction studies of tipranavir-ritonavir with clarithromycin, fluconazole, and rifabutin in healthy volunteers. Antimicrob Agents Chemother (2008) 0.78
Tuberculosis elimination in the Canadian First Nations population: assessment by a state-transfer, compartmental epidemic model. Int J Infect Dis (2009) 0.77
Use of signature-tagged mutagenesis to identify virulence determinants in Haemophilus ducreyi responsible for ulcer formation. J Microbiol Methods (2010) 0.77
Effect of resveratrol on exercise capacity: a randomized placebo-controlled crossover pilot study. Appl Physiol Nutr Metab (2014) 0.76
On the zoonosis of M. avium subspecies paratuberculosis (MAP). J Crohns Colitis (2012) 0.75
Pharmaceutical gifts of medicine. J Int Assoc Physicians AIDS Care (Chic) (2004) 0.75
The benefits and risks of bacille Calmette-Guérin vaccination among infants at high risk for both tuberculosis and severe combined immunodeficiency: assessment by Markov model. BMC Pediatr (2006) 0.75
Mouse viruses and human disease. Lancet Infect Dis (2011) 0.75
Needs and prospects for HIV therapy in developing countries. J Int Assoc Physicians AIDS Care (Chic) (2002) 0.75
Common dermatologic manifestations of herpesviruses in HIV/AIDS. J Int Assoc Physicians AIDS Care (Chic) (2004) 0.75
Epidemic HIV-associated Kaposi's sarcoma: not as common as it used to be. J Int Assoc Physicians AIDS Care (Chic) (2004) 0.75
The case for case reports. Int J Infect Dis (2010) 0.75
Identification and characterization of a heme periplasmic-binding protein in Haemophilus ducreyi. Biometals (2011) 0.75
After terror, more horrors of war. J Int Assoc Physicians AIDS Care (Chic) (2002) 0.75
Field evaluation of the Merlin immediate HIV-1 and -2 test for point-of-care detection of human immunodeficiency virus antibodies. Clin Infect Dis (2002) 0.75
"Au Revoir les Enfants" without leadership for HIV treatment in poor countries. J Int Assoc Physicians AIDS Care (Chic) (2003) 0.75
Oral immunization using HgbA in a recombinant chancroid vaccine delivered by attenuated Salmonella typhimurium SL3261 in the temperature-dependent rabbit model. J Immunol Methods (2011) 0.75